Weitere Beispiele werden automatisch zu den Stichwörtern zugeordnet - wir garantieren ihre Korrektheit nicht.
Vision problems may continue after macular edema has gone away.
If you have macular edema, laser surgery may also be used.
Participants on both treatment groups showed a reduction in macular edema symptoms over six months.
If both eyes are affected by macular edema only one is treated at a time usually a few weeks apart.
In general, however, a person with macular edema is likely to have blurred vision, making it hard to do things like read or drive.
Macular edema usually starts in the first 3 to 4 months after starting Gilenya.
Macular edema persisted for three months in nine patients.
Even macular edema, which can cause rapid vision loss, may not have any warning signs for some time.
Ten percent (10%) of diabetic patients will have vision loss related to macular edema.
It is anticipated that the research will lead to a new classification of early macular edema in people with diabetes.
About half of the people with proliferative retinopathy also have macular edema.
Some people develop a condition called macular edema.
Fingolimod has also been known to cause macular edema, resulting in decreased vision.
Other adverse events reported on the study drug included macular edema, cancer, and laboratory abnormalities.
A number of drugs can cause changes in the retina that can lead to macular edema.
Participants, who were on average in their early 60s, were diagnosed with type 1 or 2 diabetes and macular edema.
Macular edema is a common complication associated with diabetic retinopathy.
"Basically, macular edema is a very difficult entity to diagnose and to monitor," Prof.
Replacement of the lens as treatment for cataract can cause pseudophakic macular edema.
Macular edema is treated with focal laser treatment.
The causes of macular edema are numerous and different causes may be inter-related.
This helps in clearing the macular edema.
The fourth study is a Phase 2 safety and efficacy of abicipar in patients with diabetic macular edema.
This condition is called macular edema.
Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion.
The number of eyes with poor vision due to macular oedema was unexpectedly low.
Macular oedema occurs when fluid leaks from the small blood vessels in the eye.
Currently people are needlessly losing their sight from diabetic macular oedema.
All except one patient with significant vision loss (mainly due to macular oedema) were not previously screened.
Hypertension ("high blood pressure") is important, particularly when the reading vision is being affected by macular oedema.
Macular oedema may present with visual loss in someone with diabetic retinopathy.
Diabetic retinopathy especially macular oedema seems to occur earlier and to be more severe in Aboriginal people.
This is known as Macular Oedema.
At least 50,000 people in the UK have diabetic macular oedema which can leave people unable to read, work or drive.
Macular oedema is caused by fluid collecting in the central part of the retina, leading to blurred central vision and other problems.
Any vision-threatening signs (early macular oedema or proliferative retinopathy) need to be assessed for consideration of treatment.
Leaks from macular capillaries result in macular oedema.
Diabetic macular oedema (swelling of the macula) (Click image to enlarge)
Iluvien is a sustained-release implant used to treat vision impairment associated with chronic diabetic macular oedema.
Macular oedema in AIDS patients with cytomegalovirus retinitis.
Occasionally, cataract surgery may cause diabetic retinopathy to worsen, and in particular, it may exacerbate macular oedema.
Macular oedema in Aboriginal people seems to be particularly florid and this may well be due to co-existing hyperlipidaemia and hypertension.
It is routinely used to image Cystoid Macular Oedema and Diabetic Retinopathy among others.
An optician referred her to an ophthalmologist and tests showed Lisa had a macular oedema as a result of central retinal vein occlusion in both eyes.
NICE is pleased to recommend ranibizumab as a treatment option for some people with visual impairment caused by diabetic macular oedema in new draft guidance.
NICE, which decides if particular treatments should be used on the state-run health service, had previously rejected Lucentis for diabetic macular oedema.
The detection of diffuse macular oedema is an area of limited precision at least in a photographic system but the grading system should attempt to detect it.
Thirteen eyes had proliferative diabetic retinopathy and 39 had macular oedema secondary to BRVO or diabetic maculopathy.
About Macular Oedema Caused by Retinal Vein Occlusion (RVO)
Other measures of retinopathy - the development of proliferative diabetic retinopathy and progression to clinically significant macular oedema - occurred to a similar degree in both treatment groups.